is the oral semaglutide as effective as the injection vs Injectable Semaglutide: Which Works Better for Weight Loss? Wegovy vs. Ozempic: What To

Importantly, the risk of symptom rebound after discontinuation remains unexplored and warrants further investigation

Emerging preclinical research has identified GLP-1 receptors in various immune cells and tissues, leading to scientific interest in potential anti-inflammatory properties

The arrival of oral GLP-1 medication is hugely significant because it has the potential to make evidence-based obesity treatment accessible to a much wider group of patients who previously felt excluded from the current options available. Despite the excitement surrounding the launch, experts stress that the medication is not a quick fix and should be viewed as part of a broader approach to weight management

If you're not seeing expected results with your current medication, talk to your healthcare provider about potential adjustments

doi: 10.1016/j.pneurobio.2016.10.001